Abstract
One hundred sixty-eight volunteers were randomized to receive a placebo or a vitamin C supplement, two tablets daily, over a 60-day period between November and February. They used a five-point scale to assess their health and recorded any common cold infections and symptoms in a daily diary. Compared with the placebo group, the active-treatment group had significantly fewer colds (37 vs 50, P<.05), fewer days challenged virally (85 vs 178), and a significantly shorter duration of severe symptoms (1.8 vs 3.1 days, P<.03). Consequently, volunteers in the active group were less likely to get a cold and recovered faster if infected. Few side effects occurred with the active treatment, and volunteers reported greatly increased satisfaction with the study supplement compared with any previous form of vitamin C. This well-tolerated vitamin C supplement may prevent the common cold and shorten the duration of symptoms. Volunteers were generally impressed by the protection afforded them during the winter months and the general acceptability of the study medication.
Similar content being viewed by others
References
Eccles R. Common Cold Centre, Cardiff, UK. Available at: http://www.cf.ac.uk/biosci/associates/ cold/home.html.
Hemila H. Vitamin C intake and susceptibility to the common cold.Br J Nutr. 1997;77:59–72.
Hemila H. Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress.Int J Sports Med. 1996;17:379–383.
Hemila H. Vitamin C and the common cold.Br J Nutr. 1992;67:3–16.
Hemila H, Herman ZS. Vitamin C and the common cold: a retrospective analysis of Chalmers’ review.J Am Coll Nutr. 1995;14:116–123.
Audera C, Patulny R, Sander B, Douglas R. Mega-dose vitamin C in treatment of the common cold: a randomised controlled trial.Med J Aust. 2001;175:359–362.
Bush MJ, Verlangieri AJ. An acute study on the relative GI absorption of a novel form of calcium ascorbate.Res Commun Chem Pathol Pharmacol. 1987;57:137–140.
Fay MJ, Verlangieri AJ. Stimulatory action of calcium threonate on ascorbic acid uptake by a human T-lymphoma cell line.Life Sci. 1994;49:1377–1381.
Josling PD. Preventing the common cold with a garlic supplement: a double-blind placebo-controlled survey.Adv Ther. 2001;18:189–193.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Van Straten, M., Josling, P. Preventing the common cold with a vitamin C supplement: A double-blind, placebo-controlled survey. Adv Therapy 19, 151–159 (2002). https://doi.org/10.1007/BF02850271
Issue Date:
DOI: https://doi.org/10.1007/BF02850271